Donanemab

Donanemab, sold under the brand name Kisunla, is a monoclonal antibody used for the treatment of Alzheimer's disease. Donanemab was developed by Eli Lilly and Company. The most common... Wikipedia

Type: Whole antibody
Source: Humanized (from mouse)
Target: Amyloid beta
Trade names: Kisunla
data: US DailyMed: Donanemab
Routes of, administration: Intravenous
Legal status: US: ℞-only
CAS Number: 1931944-80-7
ATC code: N06DX05 (WHO)
UNII: 1ADB65P1KK
KEGG: D11500
Synonyms: LY3002813, donanemab-azbt
Data source: DuckDuckGo